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Phosphatidylinositol 3-kinase pathways play key regulatory roles in cell cycle progression into S
phase. In this study, we demonstrated that Akt1/PKBa isoform plays an essential role in G1/S transi-
tion and proliferation. Cells lacking Akt1/PKBa showed an attenuated proliferation as well as G1/S
transition, whereas cells lacking Akt2/PKBb showed normal proliferation and G1/S transition. The
effect of Akt1/PKBa on cell proliferation and G1/S transition was completely abolished by swapping
pleckstrin homology (PH) domain with that of Akt2/PKBb. Finally, full activation of Akt/PKB and
cyclin D expression was achieved by the Akt1/PKBa or chimeric proteins containing the PH domain
of Akt1/PKBa indicating that the PH domain of Akt1/PKBa provides full kinase activity and is neces-
sary for the G1/S transition.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction Akt/PKB plays a major role in a variety of PI3K-mediated phys-Proliferation of mammalian cells requires the activation of
many signaling molecules as well as regulatory cell cycle proteins.
Activation of phosphatidylinositol 3-kinase (PI3K) leads to the
generation of phosphatidylinositol 3,4,5-trisphosphate (PtdIns-
(3,4,5)P3) from phosphatidylinositol 4,5-bisphosphate (PtdIns-
(4,5)P2). PtdIns-(3,4,5)P3 is a lipid that is an important intracellular
second messenger that activates many signaling molecules includ-
ing 3-phosphoinositide-dependent protein kinase-1 (PDK-1), Akt/
protein kinase B (Akt/PKB), and Rac guanine nucleotide exchange
factors (Rac-GEFs) [1–3]. Genetic loss of the phosphatase and
tensin homolog (PTEN) function leads to the accumulation of
PtdIns-(3,4,5)P3 and results in the constitutive activation of these
signaling pathways. Since human cancers are frequently associated
with the loss of PTEN function [4,5], enhanced PI3K signaling path-
ways are thought to be important for oncogenic transformation as
well as proliferation.chemical Societies. Published by E
I3K, phosphatidylinositol 3-
isphosphate; PTEN, phospha-
pleckstrin homology; mTOR,iological responses such as proliferation, survival, metabolism, dif-
ferentiation, and migration. There are three members of the Akt/
PKB family (Akt1/PKBa, Akt2/PKBb, and Akt3/PKBc), which are en-
coded by three different genes [6]. The basic pattern of members of
the Akt/PKB family consist of (i) an amino-terminal pleckstrin
homology (PH) domain for phospholipid binding, followed by (ii)
a short linker region, a central AGC type catalytic domain, and
(iii) a short carboxy-terminal regulatory domain. Akt/PKB interacts
with PtdIns-(3,4,5)P3 through its PH domain. It undergoes confor-
mational changes due to its susceptibility to phosphorylation at
Thr308 by PDK-1. Additional phosphorylation at a secondary site
(Ser473) is required for maximum activation of Akt/PKB [7] in
which mammalian target of rapamycin (mTOR) complex 2
(mTORC2) phosphorylates [8].
Mounting evidence supports the idea that activation of Akt/PKB
is involved in cell cycle progression, and hyper-activation of the
Akt/PKB signaling pathway is frequently observed in a variety of
human cancer cells [9,10]. Activation of the PI3K signaling pathway
is speciﬁcally required for the commitment of ﬁbroblast cells to
progress to the G1/S transition [11]. Progression through the G1/S
transition is tightly regulated by the coordinated action of cyclin
and cyclin-dependent kinase (CDK) complexes. Akt/PKB controls
cyclin D1 expression through the phosphorylation and inactivation
of glycogen synthase kinase-3b (GSK-3b) which induces proteolytic
degradation of cyclin D1 [12,13]. Akt/PKB also regulates thelsevier B.V. All rights reserved.
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tional activity of the forkhead transcriptional factor class O (FoxO)
or direct phosphorylation [14,15].
Akt/PKB isoforms share 85% of the amino acid sequence homol-
ogy; however, the biological function of each isoform seems to be
different in animal models. For example, disruption of Akt1/PKBa
in mice shows growth retardation throughout their lifespan,
whereas mice lacking Akt2/PKBb show normal development [16].
Mice lacking Akt2/PKBb, however, have a mild type 2 diabetes-like
syndrome, and adipocytes derived from Akt2/PKBb knock-out mice
show impairment of GLUT4 translocation and glucose uptake
[17,18]. Finally, Akt3/PKBc is required for a normal brain size
[19]. Hence, the Akt/PKB isoform seems to play distinct roles in
many biological responses such as growth, proliferation, and
metabolism. Since the loss of Akt1/PKBa results in growth retarda-
tion, it is likely that the major function of Akt1/PKBa may be con-
trolling cellular growth and cell cycle progression.2. Materials and methods
2.1. Materials
All the cell culture reagents were purchased from Cambrex Corp.
(Charles City, IA). Anti-Akt1/PKBa, anti-Akt2/PKBb, and anti-Myc
antibodies were purchased from Upstate Biotech (Lake Placid,
NY). Anti-pAkt (Ser473) antibody was obtained from Cell Signaling
Technology (Danvers, MA). Anti-cyclin D1 antibody was purchased
from NeoMarkers (Fremont, CA). Horseradish peroxidase-
conjugated anti-rabbit or anti-mouse antibodywas purchased from
Kirkegaard and Perry Laboratories Inc. (Gaithersburg, MA). All other
high quality reagents were purchased from Sigma–Aldrich (St.
Louis, MO) unless indicated elsewhere.
2.2. Establishment of mouse embryo ﬁbroblast (MEF) cells and culture
MEF cells were isolated essentially the same way as previously
reported [17]. The cells were sub-cultured in a culture medium
(DMEM supplemented with 10% FBS and antibiotics) and main-
tained at 37 C in 5% CO2. Primary cells were immortalized by con-
tinuous culturing for 30 passages.
2.3. Plasmids construction
Myc-tagged murine Akt1/PKBa, Akt2/PKBb, and their chimeric
cDNAs were introduced into retroviral vector, pMIGR2, as de-
scribed previously [20]. All the constructs were fully sequenced
to ensure that no other mutation was introduced inadvertently.
2.4. Retroviral infection
Generation of retroviral particles and subsequent infection to
the MEF cells were performed essentially the same way as previ-
ously reported [17]. Infection was validated by GFP expression un-
der ﬂuorescent microscopy, and infected MEF cells were isolated
using FACSAria cell sorter at the same gate of ﬂuorescence
intensity.
2.5. Cell proliferation assay
A total of 2500 cells were seeded on a six-well plate and grown
for 5 days under a normal culture medium. Cells were ﬁxed with
4% paraformaldehyde, and the nucleus was stained with DAPI.
Stained cells were visualized with a ﬂuorescence microscope and
random images of four ﬁelds were taken at 20 magniﬁcation.2.6. Cell cycle analysis
A total of 5  105 cells were seeded on 10-cm dish and serum
starved for 24 h to synchronize them in the G1 phase of the cell cy-
cle. Synchronous populations of cells were subsequently treated in
the absence or presence of 10% FBS. Flow cytometry analysis was
performed using FACSCalibur (Becton Dickinson, San Jose, CA) as
described previously [21], and the data were acquired and ana-
lyzed with CellQuest software. The percentage of cells in each
phase of the cell cycle was calculated as the ratio of events in each
phase to the total number of events.
2.7. Immunoprecipitation and western blotting
An immunoprecipitation and western blotting analysis were
performed as described previously [17].
2.8. Statistical analysis
Results are expressed as the means ± S.D. of two independent
experiments (n = 3 for each experiment). When comparing two
groups, an unpaired Student’s t-test was used to address differ-
ences. P-values <0.05 were considered signiﬁcant and indicated
by *. P-values >0.05 were considered insigniﬁcant and indicated
by **.
3. Results and discussion
3.1. Akt1/PKBa is essential for MEF cell proliferation
The issue of whether Akt/PKB isoforms have speciﬁc or redun-
dant functions has recently been addressed by targeted disruption
of each Akt/PKB isoform in mice [16,18,22]. Especially, mice lack-
ing Akt1/PKBa displayed retarded organismal growth, impairment
of adipocyte differentiation, and skin development [16,22].
Although small organism size can be due to the impairment of pla-
cental development, which eventually leads to retarded fetal
growth [23], autonomous cell defects in proliferation and/or
growth might also be responsible for the small size of the animal.
To examine the role of each Akt/PKB isoform in cell proliferation,
we have generated various genotypes of MEF cells from corre-
sponding Akt/PKB knock-out embryos (WT, Akt1/PKBa+/+:Akt2/
PKBb+/+; 1KO, Akt1/PKBa/:Akt2/PKBb+/+; 2KO, Akt1/PKBa+/+:Akt2/
PKBb/; DKO, Akt1/PKBa/:Akt2/PKBb/). As shown in Fig. 1,
1KO and DKO cells showed delayed proliferation compared with
WT cells. Since there was no detectable apoptosis in cells lacking
Akt1/PKBa (data not shown), delayed proliferation might be not
due to the loss of cell survival. In contrast to Akt1/PKBa deﬁcient
cells, 2KO cells showed relatively normal proliferation compared
with WT cells but showed defects in insulin-induced GLUT4 trans-
location and glucose uptake [17]. In correlation with these results,
it has been shown that silencing Akt1/PKBa but not Akt2/PKBb by a
small interfering RNA (siRNA) results in the inhibition of prolifera-
tion [24]. Therefore, it is likely that cell proliferation is speciﬁcally
controlled by Akt1/PKBa whereas Akt2/PKBb is dispensable in the
presence of Akt1/PKBa.
To further conﬁrm the speciﬁc requirement of Akt1/PKBa dur-
ing cell proliferation, we have re-introduced each Akt/PKB isoform
into DKO cells. As shown in Fig. 1C, the expression level of each ec-
topic Akt1/PKBa and Akt2/PKBb was almost equivalent and was
about 100-fold higher than that of endogenous wild type levels.
As shown in Fig. 1D, re-expression of Akt1/PKBa in DKO cells re-
stored the impeded proliferation. However, forced expression of
Akt2/PKBb in DKO cells did not affect the proliferation. In addition,
IGF-1, which is a major determinant of organism size, induced cell
Fig. 1. Proliferation is selectively mediated by Akt1/PKBa. (A) Mouse embryo ﬁbroblasts were established as described in Section 2. Total cell lysates were subjected to
western blotting against speciﬁc antibody for Akt1/PKBa and Akt2/PKBb. (B) Cell proliferation of established MEF cells was measured. (C) Either myc-tagged Akt1/PKBa or
Akt2/PKBb was re-expressed in DKO cells and expression was veriﬁed by western blotting with indicated antibodies. (D) Cell proliferation of added-back DKO cells was
measured.
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Fig. S1). For instance, cells lacking Akt1/PKBa showed impediment
of IGF-1-induced cell proliferation, whereas Akt2/PKBb deﬁcient
cells showed equivalent proliferation with wild type cells. More-
over, IGF-1-induced DKO cell proliferation was restored by the
re-expression of Akt1/PKBa but not Akt2PKBb. Thus, Akt1/PKBa
and Akt2/PKBb exert distinct effects on cell proliferation regardless
of expression level. It is likely that Akt/PKB isoforms are function-
ally non-redundant and that the small organism size of Akt1/PKBa
null mice is partly reﬂected by cell autonomous defects in cell
proliferation.
3.2. Cells lacking Akt1/PKBa showed an impeded G1/S transition
Activation of PI3K pathway is required for G1/S progression and
inhibition of PI3K leads to G1 arrest in many cell types [25,26].
Likewise, analysis of the cell cycle has demonstrated that cells
lacking Akt1/PKBa showed an impediment of G1/S transition
(Fig. 2). For example, maximum S phase induction of WT and
2KO cells was achieved at 16 h after release of G1-synchronized
cells by the addition of 10% serum, whereas maximum S phase
induction of Akt1/PKBa deﬁcient cells was achieved at 24 h after re-Fig. 2. G1/S transition was signiﬁcantly attenuated in cells lacking Akt1/PKBa. Cells were
initiated by addition of 10% FBS and cell cycle was analyzed at the indicated time. Arrolease of G1-synchronized cells by the addition of 10% serum. We
also showed that the same cell lines lacking Akt1/PKBa showed de-
fects in 5-bromo-deoxy-uridine (BrdU) incorporation during clonal
expansion period, which is a couple of cell cycle progression during
adipocyte differentiation [27]. Therefore, impediment of prolifera-
tion in cells lacking Akt1/PKBa may be due to the delay of S phase
induction. Our results showed that the maximum S phase induc-
tion and cell proliferation were not completely blocked by the
deletion of Akt1/PKBa and Akt2/PKBb (Figs. 1 and 2). Incomplete
blockade of S phase induction or proliferation is probably due to
the presence of Akt3/PKBc (Fig. 4). Likewise, the size of mice lack-
ing Akt1/PKBa was only about 20% smaller than wild type [16]. In
these regards, our results reﬂect in vivo physiological signiﬁcance.
3.3. PH domain of Akt1/PKBa is essential for G1/S transition and
proliferation
Since we have observed a speciﬁc requirement of Akt1/PKBa for
G1/S transition (Fig. 2), we have speculated that intrinsic properties
of each Akt/PKB isoform should be different. The PH domain of Akt/
PKB plays important roles in the interaction with PtdIns-(3,4,5)P3
and phosphorylation by PDK-1 [7,28]. To address the importantG1 synchronized by serum starving for 24 h. Induction of cell cycle progression was
ws indicate maximum S phase induction of each cell type.
Fig. 3. PH domain of Akt1/PKBa is essential for the G1/S transition and cell cycle progression. (A) Schematic representation of the linear structure of Akt1/PKBa (Myc–Akt1),
Akt2/PKBb (Myc–Akt2), chimeric Akt1/PKBa containing Akt2/PKBb PH domain (Myc–PH2–Kin1), and chimeric Akt2/PKBb containing Akt1/PKBa PH domain (Myc–PH2–Kin2).
(B) Myc-tagged constructs shown in (A) were expressed in DKO cells and expression was veriﬁed by western blotting with anti-myc antibody. (C) Serum-induced cell
proliferation was measured. (D) Cells were G1 synchronized by serum starving for 24 h. Induction of cell cycle progression was initiated by addition of 10% FBS and cell cycle
was analyzed at the 16 h time point. S phase induction was expressed as % of total cell population.
688 S.J. Yun et al. / FEBS Letters 583 (2009) 685–690role of the PH domain of Akt1/PKBa and Akt2/PKBb during G1/S
transition as well as cell proliferation, we have constructed chime-
ric Akt1/PKBa that has a PH domain of Akt2/PKBb (Myc–PH2–Kin1)
or Akt2/PKBb that has a PH domain of Akt1/PKBa (Myc–PH1–Kin2),
and is expressed in DKO cells (Fig. 3A and B). Expression of Myc–
Akt1 stimulated cell cycle progression and proliferation, however,
expression of Myc–PH2–Kin1 resulted in the loss of G1/S progres-
sion as well as proliferation. In contrast, expression of Myc–Akt2
did not affect cell cycle progression and proliferation, while
expression of Myc–PH1–Kin2 restored G1/S progression and cell
proliferation (Fig. 3C and D). Therefore, it is likely that the PH do-
main of Akt1/PKBamay provide functional speciﬁcity for G1/S pro-
gression and cell proliferation.Fig. 4. The PH domain of Akt1/PKBa is necessary for phosphorylation at Ser473 and cyclin
with 10% FBS for indicated times. Cell lysates were subjected to western blotting against
Akt/PKB constructs and stimulated with 10% FBS at the indicated times. Cell lysates we
either anti-phospho-Akt (Ser473) antibody or anti-myc antibody. (C and D) Cells were s
were subjected to western blotting against anti-myc and ani-cyclin D antibodies.3.4. PH domain of Akt1/PKBa is necessary for the full activation
The PH domain of Akt/PKB plays essential roles in the transloca-
tion to the sites where PtdIns-(3,4,5)P3 accumulates, PDK-1 depen-
dent phosphorylation at Thr308, and mTORC2-dependent
phosphorylation at Ser473 [7,8,29]. Likewise, stimulation of WT
cells with serum strongly enhanced phosphorylation at Ser473 of
Akt/PKB (Fig. 4A). However, 1KO and DKO showed signiﬁcant
attenuation of Ser473 phosphorylation. In contrast to 1KO and
DKO cells, 2KO cells showed mild reduction in Ser473 phosphory-
lation. Hence, it is likely that Akt1/PKBa is predominantly activated
by serum stimulation. Although PH domain of Akt/PKB isoform
shares sequence similarity about 60%, replacing PH domain ofD expression. (A) Established MEF cells were serum starved for 24 h and stimulated
phospho-Akt (Ser473) antibody. (B) DKO cells were re-introduced with myc-tagged
re immunoprecipitated with anti-myc antibody followed by western blotting with
erum starved for 24 h and stimulated with 10% FBS for indicated times. Cell lysates
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Ser473 phosphorylation (Fig. 4B). On the other hand, substitution
of Akt2/PKBb PH domain with that of Akt1/PKBa strongly en-
hanced serum-induced Ser473 phosphorylation. Therefore, Akt1/
PKBa PH domain provides highly efﬁcient phosphorylation of the
Ser473 residue. The mechanism of how PH domain of Akt1/PKBa
provides preferential activation of Akt1/PKBa by serum is ambigu-
ous but different structural properties related with afﬁnity for
PtdIns-(3,4,5)P3 may be one of the possible explanation. For
example, Akt1/PKBa was selectively translocated to the plasma
membrane and nucleus in response to IGF-1 stimulation (Supple-
mentary Fig. S2). Translocation of Akt1/PKBa was abolished by
substitution of PH domain with that of Akt2/PKBb. In contrast,
Akt2/PKBb was translocated to the plasma membrane and nucleus
by replacing PH domain with that of Akt1/PKBa. Therefore, it is
likely that PH domain of Akt1/PKBa isoform provides preferential
translocation of Akt1/PKBa to the plasma membrane whereby
Akt1/PKBa is preferentially activated, and eventually leads translo-
cation of activated Akt1/PKBa to the nucleus where cell cycle reg-
ulators reside. It is also notable that selective Akt/PKB isoform
inhibitors have been developed based on the structural properties
of PH domain [30].
Although we provided strong evidences that Akt/PKB isoform
differentially regulates cell cycle progression and proliferation,
the exact molecular mechanism downstream of Akt/PKB is still
ambiguous. Isoform-speciﬁcity of Akt/PKB in mediating cell cycle
progression could be achieved by three different ways. For in-
stance, different expression level of each Akt/PKB isoform, different
properties of intrinsic kinase of each Akt/PKB isoform, and selective
activation of each Akt/PKB isoform could lead to the phosphoryla-
tion of downstream target molecules by isoform-speciﬁc manner.
Since over-expression of Akt2/PKBb could not restore cell cycle
progression of DKO cells (Figs. 1 and 2), different expression level
of Akt/PKB isoform seems not to be the major reason of cell cycle
progression. However, we have shown that Akt1/PKBa is selec-
tively translocated to the nucleus (Supplementary Fig. S2), and
all these events are mediated by the PH domain. Therefore, selec-
tive translocation of Akt1/PKBa to the nucleus and subsequent reg-
ulation of cell cycle controlling proteins might contribute to the
cell cycle progression. Cyclin D is one of the major cell cycle regu-
lators that control G1/S transition induced by serum or growth fac-
tors [31]. It also has been reported that cyclin D expression is
regulated by glycogen synthase kinase-3b (GSK-3b) which is an
Akt/PKB substrate [13]. It is notable that 1KO and DKO cells
showed impediment of cyclin D expression (Fig. 4C). On the other
hand, cells lacking Akt2/PKBb showed normal cyclin D expression
compared with WT cells. Furthermore, expression of cyclin D in
DKO cells was enhanced by Akt1/PKBa and Akt2/PKBb containing
Akt1/PKBa PH domain (Myc–PH1–Kin2) but not Akt2/PKBb and
Akt1/PKBa containing Akt2/PKBb PH domain (Myc–PH2–Kin1)
(Fig. 4D). Therefore, G1/S transition seems to be mainly regulated
by Akt1/PKBa in which the PH domain of Akt1/PKBa plays an
essential role in the regulation of cyclin D expression. The possible
mechanism by which Akt1/PKBa speciﬁcally regulates cyclin D
expression may be PH domain-mediated selective activation of
Akt1/PKBa (Fig. 4A) and translocation to the nucleus (Supplemen-
tary Fig. S2). However, it is also notable that Akt/PKB isoform dif-
ferentially phosphorylated pro-apoptotic protein Bad in vitro
demonstrating that intrinsic kinase properties of Akt/PKB are dif-
ferent (Supplementary Fig. S3). Therefore, PH domain-mediated
selective activation, translocation to the nucleus, and intrinsic ki-
nase properties of Akt1/PKBamay jointly provide functional selec-
tivity in the regulation of cyclin D expression.
The Akt/PKB enzyme plays a multifunctional role in many cellu-
lar physiologies. Here we showed that the PH domain of Akt1/PKBa
was linked to the full activation of Akt/PKB, regulation of cyclin Dexpression, G1/S transition, and cell proliferation. Given these re-
sults, we suggest that differential roles of Akt/PKB isoforms in
many physiologies may be reﬂected by distinct properties of PH
domain. Studies on PH domain selective activation of downstream
signaling molecules will shed more light on the evaluation of Akt/
PKB-dependent cell cycle regulation and cell proliferation.
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